CytomX Therapeutics, Inc.

Direct answer

CytomX Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CTMX.

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust clinical pipeline includes several notable drug candidates. CX-2009, an antibody-drug conjugate (ADC) designed to target CD166, is currently...

Can you invest in CytomX Therapeutics, Inc.?

Yes. CytomX Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CTMX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for CytomX Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.